Steven L. Hoerter - 13 Aug 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
13 Aug 2021
Net transactions value
$0
Form type
4
Filing time
16 Aug 2021, 17:56:04 UTC
Previous filing
23 Jul 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORIC Stock Option (right to buy) Award $0 +33,250 $0.000000 33,250 13 Aug 2021 Common Stock 33,250 $18.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares subject to the option shall vest on each monthly anniversary of August 13, 2021.